Brief: Idorsia And Mochida Enter Into License Agreement

Mochida Pharmaceutical

05/12/2019 06:03

Dec 5 (Reuters) - Idorsia Ltd  IDIA.S :
    * IDORSIA AND MOCHIDA ENTER INTO A LICENSE AGREEMENT FOR THE
SUPPLY, CO-DEVELOPMENT AND CO-MARKETING OF DARIDOREXANT IN JAPAN
    * WILL RECEIVE AN INITIAL PAYMENT OF 1 BILLION JAPANESE YEN
(APPROXIMATELY 9 MILLION SWISS FRANCS)
    * WILL BE ENTITLED TO THREE ADDITIONAL DEVELOPMENT AND
REGULATORY
MILESTONES
    * WILL ALSO BE ENTITLED TO SALES MILESTONES AND TIERED
ROYALTY
PAYMENTS BASED ON NET SALES ACHIEVED BY MOCHIDA
    * COSTS ASSOCIATED WITH CO-DEVELOPMENT OF DARIDOREXANT WILL
BE
SHARED.

Source text for Eikon:  ID:nGNE1XrfGQ 
Further company coverage:  IDIA.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))